Annual Long Term Debt
$21.30 K
-$241.60 K-91.90%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual long term debt is $21.30 thousand, with the most recent change of -$241.60 thousand (-91.90%) on September 30, 2024.
- During the last 3 years, CTXR annual long term debt has fallen by -$656.90 thousand (-96.86%).
- CTXR annual long term debt is now -97.91% below its all-time high of $1.02 million, reached on September 30, 2020.
Performance
CTXR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$21.30 K
-$63.10 K-74.76%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly long term debt is $21.30 thousand, with the most recent change of -$63.10 thousand (-74.76%) on September 30, 2024.
- Over the past year, CTXR quarterly long term debt has dropped by -$63.10 thousand (-74.76%).
- CTXR quarterly long term debt is now -97.99% below its all-time high of $1.06 million, reached on June 30, 2020.
Performance
CTXR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CTXR Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -91.9% | -74.8% |
3 y3 years | -96.9% | -74.8% |
5 y5 years | +100.0% | -74.8% |
CTXR Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -96.9% | at low | -96.6% | at low |
5 y | 5-year | -97.9% | -100.0% | -98.0% | at low |
alltime | all time | -97.9% | -100.0% | -98.0% | -100.0% |
Citius Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $21.30 K(-91.9%) | $21.30 K(-74.8%) |
Jun 2024 | - | $84.40 K(-41.8%) |
Mar 2024 | - | $145.10 K(-29.1%) |
Dec 2023 | - | $204.60 K(-22.2%) |
Sep 2023 | $262.90 K(-45.4%) | $262.90 K(-17.8%) |
Jun 2023 | - | $320.00 K(-14.6%) |
Mar 2023 | - | $374.80 K(-12.6%) |
Dec 2022 | - | $428.60 K(-10.9%) |
Sep 2022 | - | $481.20 K(-9.7%) |
Sep 2022 | $481.20 K | - |
Jun 2022 | - | $532.90 K(-8.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $582.30 K(-7.7%) |
Dec 2021 | - | $630.70 K(-7.0%) |
Sep 2021 | $678.20 K(-33.5%) | $678.20 K(-6.4%) |
Jun 2021 | - | $724.80 K(-22.4%) |
Mar 2021 | - | $933.80 K(-4.5%) |
Dec 2020 | - | $977.40 K(-4.2%) |
Sep 2020 | $1.02 M(>+9900.0%) | $1.02 M(-3.9%) |
Jun 2020 | - | $1.06 M(+13.3%) |
Mar 2020 | - | $937.20 K(-4.0%) |
Dec 2019 | - | $976.20 K(>+9900.0%) |
Sep 2019 | $0.00 | $0.00 |
FAQ
- What is Citius Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual long term debt year-on-year change?
- What is Citius Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly long term debt year-on-year change?
What is Citius Pharmaceuticals annual long term debt?
The current annual long term debt of CTXR is $21.30 K
What is the all time high annual long term debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual long term debt is $1.02 M
What is Citius Pharmaceuticals annual long term debt year-on-year change?
Over the past year, CTXR annual long term debt has changed by -$241.60 K (-91.90%)
What is Citius Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of CTXR is $21.30 K
What is the all time high quarterly long term debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly long term debt is $1.06 M
What is Citius Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, CTXR quarterly long term debt has changed by -$63.10 K (-74.76%)